THOMAS PLOTTS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2010-10-25 The undersigned, Thomas Plotts, Chief Financial Officer of Atrinsic, Inc. (the “Corporation”)...

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25